Star Metro - Onco-Innovations Extends Marketing Program

NYSE - LSE

CMSD	-0.58%	22.35	$
SCS	1.5%	10.01	$
RBGPF	-0.71%	63	$
CMSC	-0.36%	22.24	$
NGG	0.26%	73.04	$
GSK	2.34%	38.97	$
RELX	0.8%	53.79	$
RIO	0.02%	60.88	$
BTI	1.1%	42.86	$
BP	-3.78%	28.07	$
BCE	0.5%	21.92	$
RYCEF	0.68%	10.25	$
AZN	2.48%	71.71	$
BCC	-0.88%	94.5	$
JRI	1.01%	12.93	$
VOD	0.1%	9.58	$

Onco-Innovations Extends Marketing Program

BOULEVARD 25.03.2025

Onco-Innovations Extends Marketing Program

VANCOUVER, BC / ACCESS Newswire / March 25, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-Westfalen, Deutschland, email: [email protected]; telephone: +491772481220; and website: www.mcsmarket.de) ("MCS") for the continued provision of a range of online marketing services, including campaign creation, production of marketing materials, as well as research and analytics (the "Services"). The Services are expected to run until May 31, 2025, or until budget exhaustion. The Company has paid MCS CAD 600,000 for the extended term of Services, and no securities have been provided to MCS or its principals as compensation. The Services will be executed via digital channels, including Google Ads and native advertising.

Text size:

About Onco-Innovations Limited

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco's commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer.

ON BEHALF OF ONCO-INNOVATIONS LIMITED,

"Thomas O'Shaughnessy"
Chief Executive Officer

For more information, please contact:

Thomas O'Shaughnessy

Chief Executive Officer

Tel: + 1 888 261 8055
[email protected]

The CSE and Information Service Provider have not reviewed and do not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Statements Caution. This news release contains forward-looking statements relating to the further development, potential commercialization and benefits of the Company's technologies, the Company's ability to complete future research and development activities with respect thereto, and the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "potential", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to further develop, prove out or commercialize its technologies, the failure to complete further research and development activities in respect thereto, the failure to receive regulatory approval in respect of its technologies, and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.

SOURCE: Onco-Innovations Limited

View the original press release on ACCESS Newswire

Ch.Levesque--SMC

Featured

Pietro Parolin, career diplomat leading race to be pope

A seasoned diplomat who worked with Pope Francis for 12 years, Cardinal Pietro Parolin is well-known in Rome and abroad, and a serious contender to be the next pontiff.

Trump fires Kamala Harris's husband from Holocaust board

US President Donald Trump has removed Doug Emhoff, husband of his former rival Kamala Harris, from the Holocaust Memorial Council board, drawing an angry reaction.

Pakistan says India planning strike as tensions soar over Kashmir attack

Pakistan's information minister said early Wednesday that Islamabad had "credible intelligence" that India was planning an imminent military strike and he vowed a "decisive response", as worries of spiralling conflict grew over a deadly attack in Kashmir.

France accuses Russian military intelligence over cyberattacks

France on Tuesday accused Russian military intelligence of staging cyberattacks, including against an organisation involved in the Paris Olympics and President Emmanuel Macron's first election campaign in 2017.